bupropion and mecamylamine

bupropion has been researched along with mecamylamine in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.56)18.2507
2000's13 (72.22)29.6817
2010's4 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frølund, B; Jensen, AA; Krogsgaard-Larsen, P; Liljefors, T1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hurt, RD1
Damaj, MI; Lavecchia, KL; Martin, BR; Wiley, JL1
Glennon, RA; Young, R1
Dwoskin, LP; Miller, DK; Sumithran, SP1
Roddy, E1
Glick, SD; Maisonneuve, IM; Panchal, V; Taraschenko, OD1
Bevins, RA; Palmatier, MI; Siebert, HL; Wilkinson, JL; Wiltgen, SM1
Erwin, DS; Jennings, RE; Khambati, HN; Lake, JR; Malin, DH; Meyers-Paal, RL; Montellano, AL; Perales, BA; Presley, SE; Smith, TD1
James, JR; Philibin, SD; Robinson, SE; Rosecrans, JA; Vann, RE1
Shoaib, M; Wing, VC1
Rose, JE1
Caggiula, AR; Donny, EC; Levin, ME; Mays, KL; Palmatier, MI; Sved, AF1
Ebbert, JO; Elrashidi, MY1
Biała, G; Budzyńska, B; Kruk-Słomka, M; Michalak, A1
Buoli, M; Cahn, W; Serati, M1

Reviews

7 review(s) available for bupropion and mecamylamine

ArticleYear
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
    Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15

    Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Humans; Ligands; Mice; Mice, Knockout; Models, Molecular; Molecular Sequence Data; Nicotinic Agonists; Nicotinic Antagonists; Protein Conformation; Protein Subunits; Receptors, Nicotinic

2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
New medications for nicotine dependence treatment.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 1999, Volume: 1 Suppl 2

    Topics: Administration, Cutaneous; Administration, Inhalation; Bupropion; Chewing Gum; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking; Smoking Cessation; Tobacco Use Disorder

1999
Bupropion and other non-nicotine pharmacotherapies.
    BMJ (Clinical research ed.), 2004, Feb-28, Volume: 328, Issue:7438

    Topics: Administration, Inhalation; Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Bupropion; Clonidine; Dopamine Uptake Inhibitors; Drug Interactions; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking Cessation

2004
New findings on nicotine addiction and treatment.
    Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 2009, Volume: 55

    Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline

2009
Emerging drugs for the treatment of tobacco dependence: 2014 update.
    Expert opinion on emerging drugs, 2014, Volume: 19, Issue:2

    Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2014
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
    Expert review of neurotherapeutics, 2016, Volume: 16, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents

2016

Other Studies

11 other study(ies) available for bupropion and mecamylamine

ArticleYear
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
Nicotine-like discriminative stimulus effects of bupropion in rats.
    Experimental and clinical psychopharmacology, 2002, Volume: 10, Issue:2

    Topics: Animals; Bupropion; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Long-Evans

2002
Nicotine and bupropion share a similar discriminative stimulus effect.
    European journal of pharmacology, 2002, May-17, Volume: 443, Issue:1-3

    Topics: Animals; Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation

2002
Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3

    Topics: Animals; Bupropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Hippocampus; In Vitro Techniques; Kinetics; Male; Mecamylamine; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Symporters

2002
Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?
    European journal of pharmacology, 2005, Apr-25, Volume: 513, Issue:3

    Topics: Acute Disease; Animals; Bupropion; Dextromethorphan; Drug Therapy, Combination; Female; Mecamylamine; Morphine Dependence; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome

2005
Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats.
    Psychopharmacology, 2006, Volume: 184, Issue:3-4

    Topics: Amphetamine; Animals; Arecoline; Association Learning; Bupropion; Caffeine; Chlordiazepoxide; Conditioning, Classical; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Hexamethonium; Male; Mecamylamine; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Sucrose

2006
Bupropion attenuates nicotine abstinence syndrome in the rat.
    Psychopharmacology, 2006, Volume: 184, Issue:3-4

    Topics: Animals; Association Learning; Avoidance Learning; Bupropion; Conditioning, Classical; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Premedication; Rats; Rats, Sprague-Dawley; Social Environment; Substance Withdrawal Syndrome

2006
Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Brain research, 2006, Oct-30, Volume: 1117, Issue:1

    Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Presynaptic Terminals; Rats; Rats, Inbred F344; Receptors, Nicotinic; Reinforcement, Psychology; Rubidium Radioisotopes; Tobacco Use Disorder

2006
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
    Psychopharmacology, 2007, Volume: 195, Issue:3

    Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nortriptyline; Rats; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder

2007
Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.
    Psychopharmacology, 2009, Volume: 207, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Bupropion; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mecamylamine; Motivation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prazosin; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Time Factors

2009
A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:4

    Topics: Analysis of Variance; Animals; Bupropion; Cholinergic Agents; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mecamylamine; Memory; Mice; Nicotine; Pattern Recognition, Visual; Scopolamine

2014